Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.365
Filter
1.
Bol. latinoam. Caribe plantas med. aromát ; 21(2): 131-155, mar. 2022. ilus, tab
Article in English | LILACS | ID: biblio-1393364

ABSTRACT

Bacopa monnieri(L.) Wettst. (Plantaginaceae), also known as Brahmi, has been used to improve cognitive processes and intellectual functions that are related to the preservation of memory. The objective of this research is to review the ethnobotanical applications, phytochemical composition, toxicity and activity of B. monnieri in the central nervous system. It reviewed articles on B. monnieri using Google Scholar, SciELO, Science Direct, Lilacs, Medline, and PubMed. Saponins are the main compounds in extracts of B. monnieri. Pharmacological studies showed that B. monnieri improves learning and memory and presents biological effects against Alzheimer's disease, Parkinson's disease, epilepsy, and schizophrenia. No preclinical acute toxicity was reported. However, gastrointestinal side effects were reported in some healthy elderly individuals. Most studies with B. monnieri have been preclinical evaluations of cellular mechanisms in the central nervous system and further translational clinical research needs to be performed to evaluate the safety and efficacy of the plant.


Bacopa monnieri (L.) Wettst. (Plantaginaceae), también conocida como Brahmi, se ha utilizado para mejorar los procesos cognitivos y las funciones intelectuales que están relacionadas con la preservación de la memoria. El objetivo de esta investigación es revisar las aplicaciones etnobotánicas, composición fitoquímica, toxicidad y actividad de B. monnieri en el sistema nervioso central. Se revisaron artículos sobre B. monnieri utilizando Google Scholar, SciELO, Science Direct, Lilacs, Medline y PubMed. Las saponinas son los principales compuestos de los extractos de B. monnieri. Los estudios farmacológicos mostraron que B. monnieri mejora el aprendizaje y la memoria y presenta efectos biológicos contra la enfermedad de Alzheimer, la enfermedad de Parkinson, la epilepsia y la esquizofrenia. No se informó toxicidad aguda preclínica. Sin embargo, se informaron efectos secundarios gastrointestinales en algunos ancianos sanos. La mayoría de los estudios con B. monnieri han sido evaluaciones preclínicas de los mecanismos celulares en el sistema nervioso central y es necesario realizar más investigaciones clínicas traslacionales para evaluar la seguridad y eficacia de la planta.


Subject(s)
Humans , Plant Extracts/administration & dosage , Central Nervous System Diseases/drug therapy , Bacopa/chemistry , Parkinson Disease/drug therapy , Saponins/analysis , Schizophrenia/drug therapy , Triterpenes/analysis , Plant Extracts/chemistry , Central Nervous System/drug effects , Cognition/drug effects , Epilepsy/drug therapy , Alzheimer Disease/drug therapy , Phytochemicals
2.
Rev. Ciênc. Méd. Biol. (Impr.) ; 20(4): 581-585, fev 11, 2022. tab
Article in Portuguese | LILACS | ID: biblio-1359351

ABSTRACT

Introdução: do ponto de vista clínico, são muitos os elementos para a deterioração da qualidade de vida (QV) na Doença de Parkinson (DP). Objetivo: analisar a QV de idosos com DP vinculados a um programa de atenção à saúde do idoso. Metodologia: estudo transversal com 11 idosos com DP. A QV foi avaliada por meio do Parkinson's Disease Questionary-39, a incapacidade através da Escala de Hoehn e Yahr modificada (HY). As partes I (estado mental), II (atividades da vida diária), III (motricidade) e IV (complicações da terapia) da Escala Unificada de Avaliação da Doença de Parkinson (UPDRS); o tempo de doença e o gênero foram considerados para análise. Resultados: a percepção da QV foi pior no domínio mobilidade e melhor no domínio estigma. Não houve diferença na QV entre os sexos. O tempo de doença influenciou a QV referente à comunicação nos homens (p = 0,02). Houve correlação (moderada a forte) entre a QV domínio cognição com a UPDRS IV (p = 0,04). As mulheres apresentaram correlação entre a QV domínio mobilidade e a HY (p = 0,05) e a III (p = 0,04) e entre a QV domínio atividade de vida diária e a HY (p = 0,02), II (p = 0,01) e III (p = 0,01); os homens entre a QV domínio suporte social e a II (p = 0,01). Conclusão: a percepção da QV de idosos com DP vinculados a um programa de saúde foi similar entre os sexos e permeia as funções corpóreas e atividades do dia-a-dia.


Introduction: from a clinical point of view, there are many elements for the deterioration of quality of life (QoL) in Parkinson's disease (PD). Objective: analyze the QoL of elderly people with PD linked to an elderly health care program. Methodology: cross-sectional study with 11 elderly people with PD. QoL was assessed using the Parkinson's Disease Questionary-39, disability using the Modified Hoehn and Yahr Scale (HY). Parts I (mental status), II (activities of daily living), III (motor skills) and IV (therapy complications) of the Unified Parkinson's Disease Assessment Scale (UPDRS); disease duration and gender were considered for analysis. Results: The perception of QoL was worse in the mobility domain and better in the stigma domain. There was no difference in QoL between genders. The time of illness influenced the Qol regarding communucation in men (p = 0.02). There was correlation (moderate to strong) between QoL cognition domain with UPDRS IV (p = 0.04). Womem showed correlations between QoL mobility domain and HY (p = 0.05) and III (p = 0.04) and between QOL domain activity of daily living and HY (p = 0.02), II (p = 0.01) and III (p = 0.01); men between QoL social support domain and II (p = 0.01). Conclusion: Perception of the QoL of elderly people with PD linked to a health program was similar between genders and permeates bodily functions, day-to-day activities.


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Parkinson Disease , Quality of Life , Aged , Motor Activity , Epidemiology, Descriptive , Cross-Sectional Studies
3.
Fisioter. Bras ; 22(6): 824-836, Fevereiro 7, 2022.
Article in Portuguese | LILACS | ID: biblio-1358271

ABSTRACT

A Doença de Parkinson (DP) é uma doença neurodegenerativa progressiva frequente, caracterizada como grupo de risco mediante a pandemia do novo coronavirus (COVID-19). Por isso, o telemonitoramento surge como uma boa alternativa terapêutica para continuidade dos serviços de fisioterapia. Objetivo: Avaliar a frequência de atividade física, adesão e satisfação dos pacientes com DP frente ao telemonitoramento. Métodos: Trata-se de um estudo clínico longitudinal. Foram enviados, via aplicativo de mensagens, três vídeos em 9 semanas de telemonitoramento. Foram avaliadas a frequência e adesão aos exercícios e, por fim, a satisfação ao telemonitoramento. Resultados: Foram monitorados 21 pacientes. A frequência e adesão aos exercícios decresceram, apresentando melhores índices entre os homens. O nível de adesão foi maior entre aqueles que utilizaram o aplicativo de parentes próximos. Os pacientes relataram satisfação ao telemonitoramento. Conclusão: Os níveis adesão e as frequência dos exercícios foram melhores no gênero masculino e entre aqueles que fizeram uso de aplicativos de parentes próximos. O telemonitoramento é uma terapêutica alternativa. (AU)


Subject(s)
Parkinson Disease , Exercise , Physical Therapy Modalities , Coronavirus , Pandemics , Telemonitoring , COVID-19
4.
Fisioter. Bras ; 23(1): 152-172, Fev 11, 2022.
Article in Portuguese | LILACS | ID: biblio-1358610

ABSTRACT

Introdução: Mais de 85% das pessoas com Doença de Parkinson (DP) desenvolvem dificuldades de locomoção dentro de 3 anos após o diagnóstico, sendo os distúrbios da marcha considerados os sintomas motores mais incapacitantes da DP, levando a um declínio substancial na mobilidade e independência. Objetivo: Realizar uma revisão sistemática sobre os efeitos encontrados após reabilitação baseada em exercícios na marcha em pacientes com DP. Métodos: Foi realizada uma revisão sistemática buscando artigos nas bases de dados Pubmed, Lilacs, PEDro, Scielo e Scopus, com estudos publicados nos últimos dez anos. Os termos usados para pesquisa foram selecionados de acordo com o DeCS/MeSH (Descritores em Ciências da Saúde/ Medical Subject Headings). Resultados: A busca resultou em 514 estudos e 58 desses estudos foram apropriados para inclusão. Após avaliação metodológica dos 58 estudos, apenas trabalhos classificados como de alta qualidade metodológica foram incluídos. Foi verificado que programa com treinamento de marcha, fortalecimento, dupla tarefa, equilíbrio e resistência demonstram em sua maioria efeitos positivos na velocidade, cadência, comprimento da passada, comprimento do passo, capacidade e resistência da marcha. Conclusão: Os estudos apresentados nesta revisão demonstram em sua maioria efeitos positivos após reabilitação baseada em exercícios na marcha de pacientes com DP. (AU)


Subject(s)
Humans , Parkinson Disease/rehabilitation , Gait Disorders, Neurologic/rehabilitation , Exercise Therapy/methods
5.
Arq. neuropsiquiatr ; 80(2): 145-152, Feb. 2022. tab, graf
Article in English | LILACS | ID: biblio-1364364

ABSTRACT

ABSTRACT Background: Parkinson's disease (PD) is a chronic disease that presents a multitude of symptoms, with symptoms of both motor and nonmotor nature. The Delphi method is widely used to create consensuses among experts in a field of knowledge. Objective: In order to reach a consensus on the values that should be assigned to the different motor and nonmotor manifestations of Parkinson's disease, a linear evaluation index (LEI) was created. Subsequently, the metric properties of this index were studied. Methods: 120 consecutive patients with a Parkinson's diagnosis were chosen in accordance with the UKPDSBB criteria. The Delphi method was used to reach a consensus among experts regarding the values of each of the manifestations included. Subsequently, the following attributes were analyzed: quality and acceptability of the data; reliability, in terms of internal consistency, reliability index, Cronbach's alpha and standard error of measurement; and validity, in terms of convergent validity and validity for known groups. Results: Twenty-five experts participated. The importance factor did not differ between the first round and the second round (chi-square test). We analyzed the responses that assigned percentage values to the 10 dimensions of the LEI. Both in the first and in the second round, the values of the scattering coefficient Vr were always close to 0. The homogeneity index was 0.36; the corrected-item total correlation values ranged from 0.02 to 0.7; Cronbach's α was 0.69; and the SEM was 4.23 (55.1%). Conclusions: The LEI was obtained through rigorous recommended methodology. The results showed adequate metric properties.


RESUMO Antecedentes: La enfermedad de Parkinson (EP) es una enfermedad crónica que presenta una multitud de síntomas, tanto de naturaleza motora cuanto no motora. El método Delphi se utiliza ampliamente para crear un consenso entre expertos de un campo del conocimiento. Objetivos: Con el fin de llegar a un consenso sobre los valores que deben asignarse a las diferentes manifestaciones motoras y no motoras de la enfermedad de Parkinson, se creó el "Índice de Evaluación Lineal" (linear evaluation index - LEI). Posteriormente, se estudiaron las propiedades métricas de este índice. Métodos: Se eligieron 120 pacientes consecutivos con diagnóstico de Parkinson según los criterios del UKPDSBB. Se utilizó el método Delfos para llegar a un consenso entre los expertos sobre los valores de cada una de las manifestaciones incluidas. Posteriormente, se analizaron los siguientes atributos: Calidad y aceptabilidad de los datos. Fiabilidad: consistencia interna, índice de fiabilidad, alfa de Cronbach y error estándar de medida. Finalmente, Validez: validez convergente y validez para grupos conocidos. Resultados: Participaron 25 expertos, el factor de importancia entre la primera y la segunda rondas (prueba chi-cuadrado), no fue diferente. Analizamos las respuestas que asignaron valores porcentuales a las 10 dimensiones del LEI; tanto en la primera como en la segunda rondas, los valores del coeficiente de dispersión Vr siempre estuvieron cerca de 0. El índice de homogeneidad fue de 0,36; los valores corregidos de correlación ítem-total variaron de 0,02 a 0,7; alpha de Cronbach fue de 0,69. El SEM fue 4,23 (55,1%). Conclusiones: El LEI se ha obtenido siguiendo una rigurosa metodología recomendada. Los resultados han mostrado propiedades métricas adecuadas.


Subject(s)
Humans , Parkinson Disease/diagnosis , Surveys and Questionnaires , Reproducibility of Results , Consensus
6.
Arq. neuropsiquiatr ; 80(1): 56-61, Jan. 2022. tab, graf
Article in English | LILACS | ID: biblio-1360133

ABSTRACT

ABSTRACT Background: Impulsive compulsive behaviors (ICBs) can affect a significant number of Parkinson's disease (PD) patients. Objective: We have studied brain samples from a brain bank of PD patients who received apomorphine via continuous infusion in life to assess the prevalence and outcome of ICBs. Methods: A search on the Queen Square Brain Bank (QSBB) database for cases donated from 2005 to 2016 with a pathological diagnosis of idiopathic PD was conducted. Notes of all donors who used apomorphine via continuous infusion for at least three months were reviewed. Clinical and demographic data were collected, as well as detailed information on treatment, prevalence and outcomes of ICBs. Results: 193 PD cases, 124 males and 69 females, with an average age at disease onset of 60.2 years and average disease duration of 17.2 years were reviewed. Dementia occurred in nearly half of the sample, depression in one quarter, and dyskinesias in a little over 40%. The prevalence of ICBs was 14.5%. Twenty-four individuals used apomorphine infusion for more than three months. Patients on apomorphine had younger age at disease onset, longer disease duration, and higher prevalence of dyskinesias. The prevalence of de novo ICB cases among patients on apomorphine was 8.3%. Apomorphine infusion was used for an average of 63.1 months on an average maximum dose of 79.5 mg per day. Ten patients remained on apomorphine until death. Conclusions: Apomorphine can be used as an alternative treatment for patients with previous ICBs as it has low risk of triggering recurrence of ICBs.


RESUMO Antecedentes: Comportamentos impulsivo-compulsivos (CICs) podem acometer uma parcela significativa de indivíduos com doença de Parkinson (DP). Objetivo: Nós estudamos amostras de tecido cerebral de uma população de pacientes com DP de um banco de cérebros que receberam apomorfina por infusão contínua em vida, com a finalidade de avaliar a prevalência e o desfecho dos CICs. Métodos: Uma pesquisa no banco de dados do Banco de Cérebros de Queen Square foi conduzida à procura de doações recebidas entre 2005 e 2016 com diagnóstico anatomopatológico de DP idiopática. Os prontuários de todos os doadores que usaram apomorfina por infusão contínua por um período mínimo de três meses foram revisados. Dados clínicos e demográficos foram coletados, assim como informações detalhadas sobre o tratamento, prevalência e desfecho dos CICs. Resultados: 193 casos de DP, 124 do sexo masculino e 69 do sexo feminino, com idade média de início da doença de 60,2 anos e tempo médio de duração da doença de 17,2 anos, foram revisados. Aproximadamente metade dos casos apresentaram demência, um quarto depressão, e um pouco mais de 40% discinesias. A prevalência de CICs foi 14,5%. Vinte e quatro indivíduos usaram infusão de apomorfina por mais de três meses. Os pacientes que usaram apomorfina apresentaram DP mais cedo, maior duração da doença, e uma maior prevalência de discinesias. A prevalência de novos casos de CICs entre pacientes usando apomorfina foi de 8,3%. Infusão de apomorfina foi usada em média por 63,1 meses a um dose máxima média de 79,5 mg por dia. Dez pacientes permaneceram usando apomorfina até o óbito. Conclusões: Apomorfina pode ser usada como opção de tratamento alternativo para pacientes que apresentarem CICs no passado considerando seu baixo risco de causar recorrência de CICs.


Subject(s)
Humans , Male , Female , Parkinson Disease/drug therapy , Parkinson Disease/epidemiology , Dyskinesias , Disruptive, Impulse Control, and Conduct Disorders , Apomorphine , Prevalence , Retrospective Studies , Compulsive Behavior/drug therapy , Compulsive Behavior/epidemiology , Impulsive Behavior
7.
Article in Chinese | WPRIM | ID: wpr-935788

ABSTRACT

Objective: To observe the dynamic changes of brainstem locus coeruleus (LC) damage in Parkinson' s disease (PD) -like mice by paraquat (PQ) . Methods: In October 2019, 36 male C57BL/6 mice were randomly divided into the exposure group and the control group, with 18 mice in each group. The mice in the exposure group were given intraperitoneal injection of 15 mg/kg PQ, and the mice in the control group were given intraperitoneal injection of 0.9% saline, twice a week for 8 weeks. Neurobehavioral changes (pole climbing test, swimming test, open field test, tail hanging test, high plus maze test and water maze test) were observed at 4 weeks, 6 weeks and 8 weeks, respectively, and the changes of motor ability, emotion and cognitive function were evaluated. The brain tissue of mice were taken and stained with Hematoxylin-Eosin (HE) to observe the pathological changes of LC. Nissl staining was used to detect the changes of neuronal Nissl bodies in LC. Immunohistochemistry (IHC) staining was used to detect the expression of neuron nuclear antigen (NeuN) , dopamine (DA) neurons and norepinephrine (NE) neuron markers tyrosine hydroxylase (TH) , α-synuclein (α-syn) in substantia nigra (SN) and LC. The expression levels of NeuN, TH and α-syn in the midbrain and brainstem were detected by Western blotting. TUNEL staining was used to detect neuronal apoptosis in LC. Results: Compared with the 4th week of PQ exposure group, the time of pole climbing and swimming immobility were gradually increased, the ratio of open arm residence time of high plus maze test and the number of times of the platform and the residence time of platform quadrant in water maze test were gradually decreased (P<0.05) in the exposure group with the progress of exposure time. The results of HE and Nissl staining showed that the neurons in LC gradually arranged loosely, the nucleus were deeply stained, the cytoplasm was pyknosis, and the number of Nissl bodies gradually decreased (P<0.05) in the exposure group with the progress of exposure time. IHC results showed that the number of NeuN and TH positive cells in SN and LC of mice were gradually decreased, and the positive expression of α-syn was gradually increased (P<0.05) in the exposure group with the progress of exposure time. Western blotting results showed that the expression levels of NeuN and TH in the midbrain and brainstem were gradually decreased, and the expression level of α-syn was gradually increased (P<0.05) in the exposure group with the progress of exposure time. TUNEL staining showed that the apoptosis rates of neurons in LC were gradually increased (P<0.05) in the exposure group with the progress of exposure time. Conclusion: PQ induces progressive damage in the LC area of PD-like mice, which may be caused by the abnormal accumulation of pathological α-syn in the LC area.


Subject(s)
Animals , Dopaminergic Neurons , Locus Coeruleus/pathology , Male , Mice , Mice, Inbred C57BL , Paraquat/toxicity , Parkinson Disease/metabolism , Substantia Nigra , Tyrosine 3-Monooxygenase/metabolism
8.
Article in Chinese | WPRIM | ID: wpr-935768

ABSTRACT

Objective: To observe the intestinal time-dependent changes in Parkinson's disease (PD) mouse model constructed by intraperitoneal injection of paraquat (PQ) and to establish the brain-gut axis connection initially. Methods: In October 2019, 48 mice were randomly divided into treated group and control groups: treated 4-week (P-4) group, treated 6-week (P-6) group, treated 8-week (P-8) group, control 4-week (C-4) group, control 6-week (C-6) group, and control 8-week (C-8) group. The treated group was injected with 15 mg/kg PQ solution and the control group was injected with 0.9% saline (0.2 ml/20 g) by intraperitoneal injection twice a week. After the initial state (0 weeks) and the treatment at the end of 4, 6 and 8 weeks, the mood changes and motor functions of mice were assessed by neurobehavioral tests (open field test, pole climbing test, tail suspension test and elevated plus maze test) . And the number of fecal pellets for 1 h and water content were calculated to assess the functional status of the gastrointestinal tract. Western blotting experiments were performed to detect the expression levels of α-synuclein (α-syn) and tyrosine hydroxylase (TH) in the nigrostriatal region of the mouse brain, the tight junction markers zonula occludens-1 (ZO-1) and Occludin, the inflammatory markers of integrin αM subunit (CD11b) , inducible nitric oxide synthase (iNOS) , high mobility group box 1 (HMGB1) , interleukin-1β (IL-1β) , and the neuronal markers βⅢ-tubulin and α-syn protein in the colon.Immunohistochemical staining was performed to detect the expression levels of colonic tight junction proteins ZO-1 and Occludin. Immunofluorescence staining was performed to detect the expression levels of TH in the substantia nigra region of the midbrain, and the co-localization of colonic intestine neuronal marker (βⅢ-tubulin) and Ser129 α-syn in the colonic. Results: Compared with the initial state (0 weeks) and C-8 group, mice in the P-8 group had significantly higher pole climbing test scores and resting time, and significantly lower total active distance, mean active speed, percentage of open arm entry and 1 h fecal instances (P<0.05) . After poisoning, the 1 h fecal water content of model mice first increased and then decreased, the P-4 and P-6 groups were significantly higher than the simultaneous point control group, and the P-8 groups were significantly lower than the initial state (P<0.05) . Compared with control, P-4 and P-6 groups, the expression levels of ZO-1 and Occludin in the P-8 group were significantly decreased (P<0.05) . Compared with control group, the expression levels of CD11b and IL-1β in the P-4 group were significantly increased (P<0.05) . Compared with control and P-4 group, the expression levels of CD11b, iNOS, HMGB1 and IL-1β in the P-6 and P-8 groups were significantly increased (P<0.05) . Compared with the control and P-4 groups, the expression levels of βⅢ-tubulin in the colon of mice in the P-8 group were significantly decreased, and the expression levels of α-syn and Ser129 α-syn were significantly increased (P<0.05) . The expression level of Ser129 α-syn in the colon of model mice was negatively correlated with the expression level of βⅢ-tubulin (r(s)=-0.9149, 95%CI: -0.9771--0.7085, P<0.001) . Ser129 α-syn and βⅢ-tubulin co-localization in the colonic intermuscular plexus region increased gradually with the time of exposure. Compared with the control, P-4 and P-6 groups, the expression level of TH in the nigrostriatal region of the brain was significantly decreased, and the expression levels of α-syn and Ser129 α-syn were significantly increased in the P-8 group (P<0.05) . Correlation analysis showed that the relative expression level of Ser129 α-syn in the nigrostriatal region of the brain was negatively correlated with the expression level of TH in the model mice (r(s)=-0.9716, 95% CI: -0.9925--0.8953, P<0.001) . Conclusion: The PD mouse model is successfully established by PQ, and the intestinal function of the model mice is reduced in a time-dependent manner. And on this basis, it is preliminary determined that the abnormal aggregation of α-syn may be an important substance connecting the brain-gut axis.


Subject(s)
Animals , Brain-Gut Axis , Disease Models, Animal , HMGB1 Protein , Intestines , Mice , Mice, Inbred C57BL , Occludin , Paraquat/toxicity , Parkinson Disease , Tubulin , Tyrosine 3-Monooxygenase/metabolism , Water
9.
Article in English | WPRIM | ID: wpr-929241

ABSTRACT

Parkinson's disease (PD) is a multifactorial disorder of the nervous system where a progressive loss of dopaminergic neurons exist. However, the pathogenesis of PD remains undefined, which becomes the main limitation for the development of clinical PD treatment. Demethylenetetrahydroberberine (DMTHB) is a novel derivative of natural product berberine. This study was aimed to explore the neuroprotective effects and pharmacological mechanism of DMTHB on Parkinson's disease using C57BL/6 mice. A PD model of mice was induced by administration of MPTP (20 mg·kg-1) and probenecid (200 mg·kg-1) twice per week for five weeks. The mice were administered with DMTHB daily by gavage at the dose of 5 and 50 mg·kg-1 for one- week prophylactic treatment and five-week theraputic treatment. The therapeutic effects of DMTHB were evaluated by behavior tests (the open field, rotarod and pole tests), immunohistochemical staining of tyrosine hydroxylase (TH), Nissl staining and biochemical assays. The molecular mechanisms of DMTHB on the key biomarkers of PD pathological states were analyzed by Western blot (WB) and qRT-PCR. DMTHB treatment alleviated the behavioral disorder induced by MPTP-probenecid. Nissl staining and TH staining showed that the damage of dopaminergic neurons in the substantia nigra was remarkably suppressed by DMTHB treatment. Western blot results showed that the ratio of Bcl-2/Bax and TH increased, but the level of α-synuclein (α-syn) was remarkably reduced, which indicated that the apoptosis of dopaminergic neurons in mice was significantly reduced. The protein phosphorylation of p-PI3K, p-AKT and p-mTOR also increased about 2-fold, compared with the model group. Furthermore, qRT-PCR results demonstrated that the mRNA levels of pro-inflammatory cytokines, IL-1β and TNF-α, were reduced, but the level of anti-inflammatory cytokine IL-10 increased after DMTHB treatment. Finally, the cellular assay displayed that DMTHB was also a strong antioxidant to protect neuron cell line PC12 by scavenging ROS. In this study, we demonstrated DMTHB alleviates the behavioral disorder and protects dopaminergic neurons through multiple-target effects includubg anti-apoptotic, anti-inflammatory and antioxidant effects.


Subject(s)
Animals , Dopaminergic Neurons/pathology , Mice , Mice, Inbred C57BL , Parkinson Disease/pathology , Parkinsonian Disorders/chemically induced , Substantia Nigra
10.
Article in Chinese | WPRIM | ID: wpr-940983

ABSTRACT

OBJECTIVE@#To explore whether the using of mimetic peptide Gap27, a selective inhibitor of connexin 43 (Cx43), could block the death of dopamine neurons and influence the expression of Cx43 in 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease mouse models.@*METHODS@#Eighteen C57BL/6 mice were randomly divided into control group, 6-OHDA group and 6-OHDA+Gap27 group, with 6 mice in each group. Bilateral substantia nigra stereotactic injection was performed. The control group was injected with ascorbate solution, 6-OHDA group was injected with 6-OHDA solution, and 6-OHDA+Gap27 group was injected with 6-OHDA and Gap27 mixed solution. Immuno-histochemical staining was used to detect the number of dopamine neurons, quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the expression of Cx43 messenger ribonucleic acid (mRNA), immuno-fluorescence staining was used to detect the distribution of Cx43 protein, the contents of Cx43 protein and Cx43 phosphorylation at serine 368 (Cx43-ps368) in mouse midbrain were detected by Western blot.@*RESULTS@#After injection of 6-OHDA, numerous dopamine neurons in substantia nigra died as Cx43 content increased, Cx43-ps368 content decreased. Mixing Gap27 while injecting 6-OHDA could reduce the number of death dopamine neurons and weaken the changes of Cx43 and Cx43-ps368 content caused by 6-OHDA. The number of tyrosine hydroxylase (TH) immunoreactive positive neurons in 6-OHDA group decreased to 27.7% ± 0.02% of the control group (P < 0.01); The number of TH immunoreactive positive neurons in 6-OHDA+Gap27 group was (1.64±0.16) times higher than that in 6-OHDA group (P < 0.05); The content of total Cx43 protein in 6-OHDA group was (1.44±0.07) times higher than that in 6-OHDA+Gap27 group (P < 0.05) while (1.68±0.07) times higher than that in control group (P < 0.01). In 6-OHDA group, the content of Cx43-ps368 protein and its proportion in total Cx43 protein were significantly lower than that in 6-OHDA+Gap27 group (P < 0.05).@*CONCLUSION@#In 6-OHDA mouse models, mimetic peptide Gap27 played a protective role in reducing the damage to substantia nigra dopamine neurons, which was induced by 6-OHDA. The overexpression of Cx43 protein might have neurotoxicity to dopamine neuron. Meanwhile, decreasing Cx43 protein level and keeping Cx43-ps368 protein level may be the protective mechanisms of Gap27.


Subject(s)
Animals , Connexin 43/pharmacology , Disease Models, Animal , Dopaminergic Neurons/metabolism , Mice , Mice, Inbred C57BL , Oxidopamine/metabolism , Parkinson Disease/metabolism , Peptides/pharmacology , Tyrosine 3-Monooxygenase/pharmacology
11.
Article in Chinese | WPRIM | ID: wpr-939524

ABSTRACT

OBJECTIVE@#To compare the clinical efficacy between Jiao's scalp acupuncture combined with virtual reality (VR) rehabilitation training and VR rehabilitation training alone for motor dysfunction in patients with Parkinson's disease (PD).@*METHODS@#A total of 52 patients with PD were randomly divided into an observation group and a control group, 26 cases in each group. The patients in both groups were treated with routine basic treatment, and the patients in the control group were treated with VR rehabilitation training. The patients in the observation group were treated with Jiao's scalp acupuncture on the basis of the control group. The scalp points included the movement area, balance area and dance tremor control area. Both groups were treated once a day, 5 times a week for a total of 8 weeks. Before treatment and 4 and 8 weeks into treatment, the gait parameters (step distance, step width, step speed and step frequency), timed "up and go" test (TUGT) time and unified Parkinson's disease rating scale part Ⅲ (UPDRS-Ⅲ) score were compared between the two groups, and the clinical efficacy was evaluated.@*RESULTS@#Four weeks into treatment, except for the step width in the control group, the gait parameters of the two groups were improved, the TUGT time was shortened, and the UPDRS-Ⅲ scores were reduced (P<0.01, P<0.05); the step distance in the observation group was better than that in the control group, and the UPDRS-Ⅲ score in the observation group was lower than that in the control group (P<0.05). Eight weeks into treatment, the gait parameters of the two groups were improved, the TUGT time was shortened, and the UPDRS-Ⅲ scores were reduced (P<0.01); the step distance and step speed in the observation group were better than those in the control group, the TUGT time in the observation group was shorter than that in the control group, and the UPDRS-Ⅲ score in the observation group was lower than that in the control group (P<0.05, P<0.01). The total effective rate was 92.3% (24/26) in the observation group, which was higher than 69.2% (18/26) in the control group (P<0.05).@*CONCLUSION@#Jiao's scalp acupuncture combined with VR rehabilitation training could improve the gait parameters, walking ability and motor function in patients with PD. The clinical effect is better than VR rehabilitation training alone.


Subject(s)
Acupuncture Therapy/adverse effects , Gait , Humans , Parkinson Disease/therapy , Scalp , Virtual Reality
12.
Article in Chinese | WPRIM | ID: wpr-927995

ABSTRACT

Under the guidance of the traditional Chinese medicine(TCM) theory of "Zangfu-organs of spleen and stomach" and the modern theory of "microbiota-gut-brain axis", this study explored the effects of Nardostachys jatamansi on the gut microbiota of rats with Parkinson's disease(PD). The 40 SD rats were randomly divided into the control group, PD model group, levodopa group, and Nardostachys jatamansi ethanol extract group. The PD model was established by subcutaneous injection of rotenone in the neck and back area. After 14 days of intragastric administration, the PD rats' behaviors were analyzed through open field test, inclined plane test, and pole test. After the behavioral tests, the striatum, colon, and colon contents of rats in each group were collected. Western blot was employed to detect the protein expression of tyrosine hydroxylase(TH) and α-synuclein(α-syn) in striatum and that of α-syn in colon. Enzyme linked immunosorbent assay(ELISA) was used to detect the levels of tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), and nuclear factor-kappa B(NF-κB) in striatum and colon. High-throughput sequencing of 16 S rRNA gene was conducted to detect the differences in microbial diversity, abundance, differential phyla, and dominant bacteria of rats between groups. The results indicated that Nar. ethanol extract could relieve dyskinesia, reverse the increased levels of α-syn, TNF-α, IL-1β, and NF-κB in striatum, and improve the protein expression of TH in striatum of PD rats. The α diversity analysis indicated a significant decrease in diversity and abundance of gut microbiota in the PD model. The results of linear discriminant analysis effect size(LEfSe) of dominant bacteria indicated that Nardostachys jatamansi ethanol extract increased the relative abundance of Clotridiaceae, Lachnospiraceae, and Anaerostipes, and reversed the increased relative abundance of Proteobacteria, Gammaproteobacteria, Enterobacteriaceae, and Escherichia-Shigella in PD model group to exhibit the neuroprotective effect. In summary, the results indicated that Nar. ethanol extract exert the therapeutic effect on PD rats. Specifically, the extract may regulate gut microbiota, decrease the levels of proinflammatory cytokines, and reduce the protein aggregation of α-syn in the colon and striatum to alleviate intestinal inflammation and neuroinflammation. This study provides a basis for combining the theory of "Zangfu-organs of spleen and stomach" with the theory of "microbiota-gut-brain axis" to treat PD.


Subject(s)
Animals , Gastrointestinal Microbiome , NF-kappa B/metabolism , Nardostachys/metabolism , Parkinson Disease/drug therapy , Rats , Rats, Sprague-Dawley
13.
Article in Chinese | WPRIM | ID: wpr-927413

ABSTRACT

OBJECTIVE@#To compare the curative effect of panlong needling at Jiaji (EX-B 2) combined with western medication and western medication alone on motor dysfunction in patients with Parkinson's disease (PD) of liver and kidney deficiency.@*METHODS@#A total of 98 patients with PD were randomly divided into an acupuncture and medication group (49 cases, 1 case dropped off) and a western medication group (49 cases,1 case was removed). The patients in the western medication group were given oral of levodopa and benserazide hydrochloride tablets, 125 mg each time, three times a day in the 1st week, and the dose was increased according to the needs of the patients' condition from the 2nd week until 250 mg each time, three times a day, for 16 consecutive weeks. On the basis of the same western medication treatment as the western medication group, panlong needling was applied at Jiaji (EX-B 2) from C2 to L5 in the acupuncture and medication group, once a day, 20 times as a course of treatment, for 4 consecutive courses. The scores of unified Parkinson's disease rating scale (UPDRS-Ⅲ, UPDRS-Ⅳ), TCM symptoms score, and 39-item Parkinson's disease questionnaire (PDQ-39) score were evaluated before treatment, after treatment and during follow-up of 1 month after treatment, respectively. The safety of the two groups was compared.@*RESULTS@#After treatment and during follow-up, except the PDQ-39 score of the western medication group, the scores of UPDRS-Ⅲ, UPDRS-Ⅳ, TCM syndrome and PDQ-39 were lower than those before treatment in the two groups (P<0.05), and the scores of above indexes in the acupuncture and medication group were lower than those of the western medication group (P<0.05). The total incidence of adverse reactions in the acupuncture and medication group was 10.4% (5/48), which was lower than 29.2% (14/48) in the western medication group (P<0.05).@*CONCLUSION@#Panlong needling at Jiaji (EX-B 2) combined with western medication could significantly improve the motor dysfunction and clinical symptoms, improve the quality of life and has high safety, and the efficacy is superior to western medication alone.


Subject(s)
Acupuncture Points , Acupuncture Therapy , Chlorophenols , Humans , Kidney , Liver , Parkinson Disease/therapy , Quality of Life , Treatment Outcome
14.
Neuroscience Bulletin ; (6): 1-15, 2022.
Article in English | WPRIM | ID: wpr-922671

ABSTRACT

Parkinson's disease (PD) is the second most common and fastest-growing neurodegenerative disorder. In recent years, it has been recognized that neurotransmitters other than dopamine and neuronal systems outside the basal ganglia are also related to PD pathogenesis. However, little is known about whether and how the caudal zona incerta (ZIc) regulates parkinsonian motor symptoms. Here, we showed that specific glutamatergic but not GABAergic ZIc


Subject(s)
Animals , Mice , Neurons , Parkinson Disease , Parkinsonian Disorders , Substantia Nigra , Zona Incerta
15.
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1398833

ABSTRACT

Objetivo: apresentar o estado da arte das publicações expressas na literatura cientifica mundial sobre a temática, bem como identificar os benefícios terapêuticos da Cannabis medicinal no tratamento dos sintomas das doenças neurodegenerativas especificamente doenças de Parkinson, esclerose múltipla e Alzheimer. Método: trata-se de uma revisão integrativa da literatura, cuja busca de dados foi realizada nas bibliotecas virtuais. Web of Science, Scopus, Medline, Lilacs, Cochrane Library e Scielo no período de agosto a outubro de 2021. Resultados: foram encontrados 158 artigos. Vinte e tres artigos foram selecionados para serem lidos na íntegra e 8 atenderam aos critérios desta revisão. Conclusão: as evidências mostram que embora cada vez mais prescritos ou autorizados, a cannabis medicinal ou os Canabinóides para a doenças neurodegenerativas continuam a ser controversos para muitos médicos.


Objective: to present the state of the art of publications expressed in the world Scientific literature on the subject, as well as to identify the therapeutic benefits of medicinal cannabis in the treatment of neurodegenerative diseases, specifically, Parkinson's diseases, multiple sclerosis and Alzheimer's. Method: this is an integrative literature review, whose data search was performed in virtual librares. Web of Science, Scopus, Medline, Lilacs, Cochrane Library and Scielo from August to October 2021. Results:158 articles were found. Twenty-three articles were selected to be read in full and 8 met the criteria of this review. Conclusion: evidence shows that although increasingly prescribed or authorized, medical cannabis or Cannabinoids for chronic pain remain controversial for many physicians.


Objetivo: presentar el estado del arte de las publicaciones expresadas en la literatura científica mundial sobre el tema, así como identificar los beneficios terapéuticos del cannabis medicinal en el tratamiento de enfermedades neurodegenerativas, en concreto, las enfermedades de Parkinson, la esclerosis múltiple y el Alzheimer. Método: se trata de una revisión integradora de la literatura, cuya búsqueda de datos se realizó en bibliotecas virtuales. Web of Science, Scopus, Medline, Lilacs, Cochrane Library y Scielo de agosto a octubre de 2021. Resultados: se encontraron 158 artículos. Se seleccionaron veintitrés artículos para ser leídos en su totalidad y ocho cumplieron los criterios de esta revisión. Conclusión: la evidencia muestra que, aunque cada vez más se prescribe o autoriza, el cannabis medicinal o los cannabinoides para el dolor crónico siguen siendo controvertidos para muchos médicos.


Subject(s)
Humans , Male , Female , Cannabinoids/therapeutic use , Cannabis/drug effects , Neurodegenerative Diseases/drug therapy , Medical Marijuana , Parkinson Disease/therapy , Chronic Pain/therapy , Multiple Sclerosis/therapy
16.
Article in English | LILACS | ID: biblio-1378980

ABSTRACT

Aims: whilst Nordic Walking (NW) practice is spreading worldwide, few studies have addressed the issue of intersubjectivity and the perception of PD individuals practicing NW and its possible impact on their daily life across different countries and cultures. This pilot study sought to explore the possible relationship between the habit of practicing NW and the perception of functionality and quality of life in the participants' cultural context. Methods: the focus group (FG) technique was used, with 10 individuals participating in a NW program. Results: content analysis revealed five main discourse categories: a) "NW benefits for people with PD"; b) "incorporation of the NW poles in daily life"; c) "Belonging to a NW group as a treatment aid"; d) "how PD people feel about their condition"; and, finally, e) "the present and the future: expectations and issues". Conclusion: in general, NW was found to generates positive content regarding coping with PD, beyond the biomechanical and quantitative functional effects previously studied. We suggest NW might be an important adjuvant resource for improving perceived functionality among people with PD.


Objetivos: embora a prática de Caminhada Nórdica (CN) esteja se espalhando pelo mundo, poucos estudos abordaram a questão da intersubjetividade e a percepção dos indivíduos com doença de Parkinson que praticam CN e seu possível impacto em sua vida diária em diferentes países e culturas. Este estudo piloto buscou explorar a possível relação entre o hábito de praticar CN e a percepção de funcionalidade e de qualidade de vida no contexto cultural dos participantes. Métodos: foi utilizada a técnica de grupo focal, com 10 indivíduos participantes de um programa de CN. Resultados: a análise de conteúdo revelou cinco categorias discursivas principais: a) "Benefícios da CN para pessoas com doença de Parkinson"; b) "incorporação dos bastões de CN na vida diária"; c) "pertencer a um grupo de CN como recurso auxiliar de tratamento"; d) "como as pessoas com doença de Parkinson se sentem sobre sua condição"; e, por fim, e) "o presente e o futuro: expectativas e questões". Conclusão: de maneira geral, a CN gerou conteúdo positivo sobre o enfrentamento da doença de Parkinson, além dos efeitos biomecânicos e funcionais quantitativos previamente estudados. Sugerimos que a CN possa ser um recurso adjuvante importante para melhorar a percepção de funcionalidade em pessoas com doença de Parkinson.


Subject(s)
Parkinson Disease , Quality of Life , Adaptation, Psychological , Nordic Walking
17.
Esc. Anna Nery Rev. Enferm ; 26: e20210131, 2022. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-1360443

ABSTRACT

RESUMO Objetivo identificar os fatores associados ao risco de quedas entre as pessoas com doença de Parkinson cadastradas na Associação Parkinson Santa Catarina. Método estudo transversal exploratório descritivo e de abordagem quantitativa, realizado com 53 pessoas cadastradas na Associação Parkinson Santa Catarina, no município de Florianópolis, Brasil, no período de junho a setembro de 2019. Foram aplicados questionário sociodemográfico, Escala de Hoehn e Yahr, Mini Exame do Estado Mental e Teste de Rastreio do Risco de Queda no Idoso. Os dados foram tabulados e analisados por meio do Sistema online de Ensino-Aprendizagem de Estatística SEstatNet®. Resultados foram identificados fatores de risco, como sexo, aumento da idade, redução da força muscular, instabilidade postural e diminuição da velocidade da marcha. Em relação aos estágios da doença, foi constatado que em todos houve piora da velocidade da marcha e o medo de cair é constante, aumentando com o agravamento da doença e o tempo de diagnóstico. Conclusão e implicações para a prática ao aprofundar o estudo do tema, o enfermeiro consegue compreender os acometimentos motores que levam à fragilização e à queda em pessoas com doença de Parkinson, elaborando estratégias para preveni-las.


RESUMEN Objetivo identificar los factores asociados al riesgo de caídas en personas con enfermedad de Parkinson registradas en la Asociación de Parkinson Santa Catarina. Método estudio descriptivo exploratorio transversal, con abordaje cuantitativo realizado con 53 personas registradas en la Asociación Parkinson Santa Catarina, en la ciudad de Florianópolis, Brasil, de junio a septiembre de 2019. Se aplicaron un cuestionario sociodemográfico, la Escala de Hoehn y Yahr, el Mini Examen del Estado Mental y la Prueba de Detección del Riesgo de Caídas en Ancianos. Los datos se tabularon y analizaron utilizando el Sistema en línea de enseñanza-aprendizaje de estadísticas SEstatNet®. Resultados se identificaron factores de riesgo como sexo, mayor edad, disminución de la fuerza muscular, inestabilidad postural y disminución de la velocidad de la marcha. En cuanto a las etapas de la enfermedad, se encontró que en todas ellas se produjo un empeoramiento de la velocidad de la marcha y el miedo a caer es constante, aumentando con el empeoramiento de la enfermedad y el momento del diagnóstico. Conclusión e implicaciones para la práctica al profundizar en el estudio del tema, el enfermero es capaz de comprender las deficiencias motoras que conducen a la fragilidad y caída en personas con enfermedad de Parkinson, ideando estrategias para prevenirlas.


ABSTRACT Objective to identify the factors associated with risk of falls among people with Parkinson's disease registered at the Parkinson Santa Catarina Association. Method this is a cross-sectional exploratory descriptive study with a quantitative approach, carried out with 53 people registered at the Parkinson Santa Catarina Association, in the city of Florianópolis, Brazil, from June to September 2019. Sociodemographic questionnaire, Hoehn and Yahr scale, Mini Mental State Examination and Simple Screening Test for Risk of Falls in the Elderly were applied. The data were tabulated and analyzed using the SEstatNet® Statistics Teaching-Learning Online System. Results risk factors were identified, such as sex, increased age, reduced muscle strength, postural instability and decreased gait speed. Regarding the stages of the disease, it was found that in all of them there was a worsening of gait speed and the fear of falling is constant, increasing with the worsening of the disease and diagnosis time. Conclusion and implications for practice by deepening the study of the topic, nurses are able to understand the motor impairments that lead to frailty and fall in people with Parkinson's disease, developing strategies to prevent them.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Parkinson Disease/diagnosis , Accidental Falls/statistics & numerical data , Risk Groups , Levodopa/therapeutic use , Visual Acuity , Comorbidity , Chronic Disease , Cross-Sectional Studies , Risk Factors , Drug Interactions , Walking Speed , Pramipexole/therapeutic use
18.
Rev. odontol. UNESP (Online) ; 51: e20220003, 2022. tab, ilus
Article in English | LILACS, BBO | ID: biblio-1389707

ABSTRACT

Abstract Introduction The elderly are among those most affected by Covid-19, and among them are people with Parkinson's disease. Social distancing, due to the coronavirus, has led to new strategies and tools for health monitoring. Objective To describe the oral health conditions, using telemonitoring, of people with Parkinson's disease during the Covid-19 pandemic. Material and method This is an analytical, quantitative, cross-sectional study. The tool used was the video call. The telephone contacts (n=154) were obtained from lists of patients in the Pro-Parkinson Extension Program at the Federal University of Pernambuco. A semi-structured questionnaire was used to gather sociodemographic data and daily oral hygiene practices for teeth and dentures, and whether or not the participant needed dental treatment, during the Covid-19 pandemic. Result The final sample consisted of 64 Parkinsonian patients. Regarding oral health care, the frequency of hygiene in this period was three times a day among 48.44% of participants, with toothbrush and toothpaste being the items most used for this task. More than half of the sample used dental prostheses. The most common oral health problems during this isolation period were pain, mouth sores and the need for tooth extraction. Conclusion Telemonitoring was essential because it was noted that these patients were deficient in their knowledge of basic hygiene practices and in information on oral health, as well as in the care of dental prostheses.


Resumo Introdução Dentre a população mais atingida pela Covid-19 estão os idosos, dentre estes, existem aqueles que têm a doença de Parkinson. Com o distanciamento social devido ao coronavírus, novas estratégias e ferramentas estão sendo utilizadas para o acompanhamento em saúde. Objetivo Descrever as condições de saúde bucal, por meio do telemonitoramento, de pessoas com Parkinson em tempos de Covid-19. Material e método Trata-se de um estudo analítico, quantitativo, de corte transversal. A ferramenta utilizada foi a de videochamada. Os contatos telefônicos foram obtidos das listagens de 154 pacientes do Programa de Extensão Pró-Parkinson da Universidade Federal de Pernambuco. Foi aplicado um questionário semi-estruturado com dados sociodemográficos e práticas diárias de higienização bucal de dentes e próteses, como também se o participante teve ou não necessidade de tratamento odontológico em tempos de Covid-19. Resultado A amostra final foi composta por 64 parkinsonianos. Com relação aos cuidados com a saúde bucal, a frequência de higienização neste período foi de três vezes por dia em 48,44% dos participantes, sendo a escova dental e o creme dental os itens mais utilizados para essa tarefa. Mais da metade da amostra faziam uso de prótese dentária. Os problemas de saúde bucal, mais prevalentes durante esse período de isolamento foram: dor, ferida na boca e necessidade de extração dentária. Conclusão O telemonitoramento foi essencial, pois se tratando da saúde bucal, notou-se que existe ainda um défice muito grande desses pacientes, tanto nas práticas de higienização básicas e informação sobre saúde bucal, como nos cuidados com as próteses dentárias.


Subject(s)
Oral Hygiene , Parkinson Disease , Aged , Oral Health , Surveys and Questionnaires , Teledentistry , COVID-19 , Coronavirus , Telemonitoring
19.
Rev. Esc. Enferm. USP ; 56: e20210367, 2022. graf
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1365413

ABSTRACT

ABSTRACT Objective: to map and analyze the scientific literature on nursing care aimed at people with Parkinson's disease in Primary Health Care. Method: this is a scoping review using the Joanna Briggs Institute methodology, carried out between July and October 2020, and updated in November 2021 in six databases from nursing care and Parkinson's disease descriptors, and their respective acronyms and synonyms in English, Portuguese and Spanish. Results: a total of 44 publications were included in this review, which identified as nursing care in Primary Care: assessment of motor and non-motor functions; management of activities of daily living and instrumental activities of daily living; disease self-management education for people with Parkinson's and their care partners; supervised group approach; and personal factor management. Conclusion: Nursing care for people with Parkinson's at the primary level essentially involves actions that include providing focused care at an individual and group level, encompassing clinical assessment, patient education, patient involvement in the social context of care, and developing positive relationships with family members and caregivers.


RESUMEN Objetivo: mapear y analizar la literatura científica sobre el cuidado de enfermería dirigido a personas con enfermedad de Parkinson en la Atención Primaria de Salud. Método: una revisión del alcance utilizando la metodología del Joanna Briggs Institute, realizada entre julio y octubre de 2020, y actualizada en noviembre de 2021 en seis bases de datos, de los descriptores cuidado de enfermería y enfermedad de Parkinson, y sus respectivas siglas y sinónimos en inglés, portugués y español. Resultados: en esta revisión se incluyeron 44 publicaciones, que identificaron como cuidados de enfermería en Atención Primaria: evaluación de las funciones motoras y no motoras; gestión de Actividades de la Vida Diaria y Actividades Instrumentales de la Vida Diaria; educación para el autocontrol de enfermedades para personas con Parkinson y sus cuidadores; enfoque de grupo supervisado; y manejo de factores personales. Conclusión: la atención de enfermería a las personas con Parkinson en el nivel primario implica esencialmente acciones que incluyen brindar cuidados enfocados a nivel individual y grupal, incluyendo la evaluación clínica, educación del paciente, participación del paciente en el contexto social de la atención y desarrollo de relaciones positivas con los miembros de la familia y los cuidadores.


RESUMO Objetivo: mapear e analisar a literatura científica acerca dos cuidados de enfermagem direcionados às pessoas com doença de Parkinson na Atenção Primária à Saúde. Método: revisão de escopo utilizando a metodologia do Joanna Briggs Institute, realizada entre julho e outubro de 2020, e atualizada em novembro de 2021 em seis bases de dados, a partir dos descritores cuidados de enfermagem e doença de Parkinson, e seus respectivos acrônimos e sinônimos em inglês, português e espanhol. Resultados: foram incluídas 44 publicações nesta revisão, que identificaram como cuidados de enfermagem na Atenção Primária: avaliação das funções motoras e funções não motoras; gerenciamento das Atividades de Vida Diária e das Atividades Instrumentais de Vida Diária; educação para autogestão da doença para pessoas com Parkinson e seus parceiros de cuidado; abordagem supervisionada em grupo; e gerenciamento dos fatores pessoais. Conclusão: os cuidados de enfermagem à pessoa com Parkinson no âmbito primário envolvem, essencialmente, ações que incluem prestar cuidados centrados em nível individual e em grupo, abrangendo avaliação clínica, educação do paciente, envolvimento deste no contexto social do cuidado e desenvolvimento de relacionamentos positivos com os familiares e cuidadores.


Subject(s)
Parkinson Disease , Primary Health Care , Nursing , Review , Noncommunicable Diseases , Nursing Care
20.
Article in English | LILACS-Express | LILACS | ID: biblio-1384317

ABSTRACT

ABSTRACT: Parkinson's disease can harm the functional capacity of a person, which may lead to a worse motor coordination and balance, increasing the risk of falls, and consequently to morbidities or even death. So, complimentary therapies to the drug therapy as exercise programs the aim to increase coordination and balance may avoid the possible falls that may occur and to increase the life quality for people with this illness. Thus, the present study is aimed to verify the efficiency of a four-week exercise program formed by balance and motor coordination on people living with Parkinson using Berg scale to evaluate it. Twelve individuals (64.18 ± 9.54 years; 73.83 ± 14.97 kg; 168.25 ± 8.24 cm) were submitted to two sessions each week consisted of exercises divided in three series of 90 seconds, in a total of eight sessions. The Berg scores increase significatively (p = 0.033) from 43.58 ± 6.53 to 46 ± 5.22. Since scores less than 45 mean a high probability of falls, it is possible to say that the applied program was effective in increase the balance for these individuals, consequently, leading to a better functional capacity and a possible better life quality.


RESUMEN: La enfermedad de Parkinson deteriora la capacidad funcional del paciente al afectar su coordinación motora y el equilibrio, lo que puede provocar caídas y, en consecuencia, morbilidades asociadas o incluso la muerte. De esta manera, las terapias auxiliares de la terapia farmacológica, como los programas de ejercicio físico que buscan mejorar la coordinación y el equilibrio, pueden ayudar a evitar el riesgo de caídas y, por lo tanto, mejorar la calidad de vida de las personas afectadas por esta enfermedad. Por tanto, el presente estudio tiene como objetivo verificar la efectividad de un programa de ejercicios de cuatro semanas que incluye ejercicios de equilibrio y coordinación motora para mejorar el equilibrio de las personas con Parkinson, utilizando la escala de Berg. Doce personas (64,18 ± 9,54 años; 73,83 ± 14,97 kg; 168,25 ± 8,24 cm) se sometieron a dos sesiones semanales de ejercicios divididos en tres series de 90 segundos para cada ejercicio, para un total de ocho sesiones. La puntuación de los individuos en la escala de Berg aumentó significativamente (p = 0,033) de 43,58 ± 6,53 a 46 ± 5,22. Sabiendo que los puntajes inferiores a 45 significan una probabilidad considerable de caídas, es posible afirmar que el programa de ejercicio aplicado fue efectivo para mejorar el equilibrio de los individuos y, en consecuencia, puede conducir a una mejora en la capacidad funcional del individuo y una posible mejora en la calidad de vida.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Parkinson Disease/therapy , Exercise , Postural Balance , Quality of Life , Accidental Falls , Accidental Falls/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL